John Labiak
Orthopaedic Surgery · Smithtown, NYNPI 1396747267
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,742 of the $3,961 with a category attached, or 69.2%. Globus Medical accounts for 77.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $3,262 and has fallen 95.2% since, to $156 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NY, where the typical reported total is $4,024.
Across 19 payments — averaging $208.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$3K
- Medtronic$306
- Stryker$250
- Medicrea USA, Corp.$141
- Si-bone, Inc.$106
- Johnson & Johnson$40
- plus $48 from 2 others
What the payments were for
- Travel & lodging$2,74269%
- Food & beverage$1,21931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 9 | $3,069 |
| Medtronic(2 entities) | 3 | $306 |
| Stryker | 2 | $250 |
| Medicrea USA, Corp. | 1 | $141 |
| Si-bone, Inc. | 1 | $106 |
| Johnson & Johnson | 1 | $40 |
| Spineology Inc. | 1 | $29 |
| Cerapedics Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TLX$2,854
- PLIF$2,732
- Pulse$2,732
- RELINE$2,732
- Bendini$303
- INTELLIS$300
- NEW PRODUCT DEVELOPMENT$221
- Excelsius - GPS$156
- PASS-LP$141
- UNiD$141
How this compares
$3,961 in reported general payments places this provider in the 45th percentile of 1,079 orthopaedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 32 | $852 |
| Meloxicam | 25 | $520 |
| Celecoxib | 25 | $184 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Smithtown
- Anthony RomeoNew York$26.8M
- Lawrence LenkeNew York$26.8M
- Edwin SuNew York$13.2M
- William RicciNew York$11.6M
- Steven HaasNew York$11.3M
- Giles ScuderiNew York$10.7M
- Joseph ZuckermanNew York$9.9M
- Evan FlatowNew York$9.6M
- Bradford ParsonsNew York$9.4M
- Geoffrey WestrichNew York$7.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.